Bogazici CT3, is a next-generation health-technology center that accelerates research and entrepreneurship in medical devices, biotechnology, and pharmaceutical technologies, aiming to transform innovation into products. Established in 2024 with the support of Ministry of Industry and Technology, CT3 builds on 15+ years of experience and infrastructure of Bogazici University LifeSci. CT3 offers an integrated idea-to-product R&D infrastructure; Cleanroom, Test & Analysis, Preclinical Imaging Units and turn-key laboratories. By connecting academia, industry, and startups, it accelerates validation, prototyping, and stakeholder matchmaking. Bogazici CT3’s goal is to create a sustainable and globally competitive health-tech ecosystem that transforms scientific discoveries in targeted therapy technologies into clinical and commercial applications.